-
Anti-HMGB1 Rabbit Monoclonal Antibody Guide
2026-09-04
MA3057 is an affinity-purified rabbit monoclonal antibody for detecting HMGB1 in human, mouse, and rat research samples by Western blot, immunohistochemistry, and flow cytometry. It supports analytical and chromatin protein detection workflows but is not intended for diagnostic, therapeutic, or medical use.
-
Intermedin, NAMPT/PARP1, and VSMC Senescence
2026-09-04
The reference study identifies an intermedin–NAMPT–NAD+–PARP1 pathway that limits DNA damage and senescent phenotype transition in aortic vascular smooth muscle cells exposed to angiotensin II. Its mouse and cell-based experiments connect a cardiovascular peptide signal with metabolic support for DNA-damage responses, while also defining important limits for translation beyond vascular aging.
-
O-GlcNAc, HUWE1, and Ferroptosis in Preeclampsia
2026-09-03
A 2026 study identifies an O-GlcNAc–HUWE1–TfR1 pathway that links trophoblast iron handling to ferroptosis and defective syncytialization in preeclampsia. Its combined placental, proteomic, cellular, and animal evidence suggests that regulating this axis may reduce oxidative trophoblast injury, although translation beyond experimental models remains unestablished.
-
CTP Solution (100 mM) in p21 mRNA Workflows
2026-09-03
CTP Solution (100 mM) provides a defined Cytidine-5'-triphosphate input for in vitro transcription workflows supporting p21 mRNA–LNP research. This article connects nucleotide quality, assay controls, and localized delivery evidence without overstating product-specific therapeutic claims.
-
DOTAP Workflows for Nucleic Acid Delivery
2026-09-02
DOTAP provides a practical cationic-lipid platform for transient gene expression, RNA delivery, antisense studies, and functional genomics. This workflow-focused guide connects formulation control with the immune-metabolic insights of a recent nano-zoledronate study while clearly separating validated findings from optimization recommendations.
-
BV6: Reframing IAP Antagonism for Translation
2026-09-02
BV6 is a Smac mimetic and selective IAP antagonist that links apoptosis induction in cancer cells with radiosensitization and combination-treatment research. This thought-leadership analysis places BV6 within a broader translational framework, using recent ovarian cancer cachexia findings to clarify why molecular cell-death signals must be evaluated alongside tissue-level outcomes.
-
HLY78: A Causal Wnt Assay Design Guide
2026-09-01
HLY78 is a Wnt/β-catenin pathway modulator that enables ligand-dependent pathway interrogation. This guide connects its Axin–LRP6 mechanism with assay design, zebrafish development, and cautious fibrosis-model interpretation.
-
Phosphatase Inhibitor Cocktail 1 for Cardiac Signaling
2026-09-01
Protect phosphorylation-dependent signaling while profiling UBA1–ATG5 regulation in cardiac hypertrophy models. This 100X DMSO formulation combines alkaline and serine/threonine phosphatase coverage for Western blotting, co-immunoprecipitation, pull-down assays, and phosphoproteomic workflows.
-
Propidium Iodide: From Signal to Strategy
2026-08-31
A translational guide to using Propidium iodide as a mechanistic readout of membrane integrity, DNA content, and treatment response in oncology research.
-
Cepharanthine: From Apoptosis to Translation
2026-08-31
Cepharanthine is a biscoclaurine alkaloid with a translationally attractive profile spanning apoptosis research, endometriosis models, cancer biology, and chemotherapy support. This article connects its mechanistic signals to practical model selection, evidence grading, formulation strategy, and the decisions required to move from promising preclinical data toward clinically relevant development.
-
Streptavidin-FITC for Sialylation Adhesion Assays
2026-08-30
Streptavidin-FITC converts biotinylated probes, antibodies, and nucleic acids into a practical fluorescence readout for cell-surface glycosylation and bacterial adhesion studies. Its FITC signal supports microscopy, tissue staining, and flow cytometry workflows that can connect ST3GAL1-dependent sialylation with Fusobacterium nucleatum binding.
-
Risedronate Sodium: Inhaled and Cellular Workflows
2026-08-29
Risedronate Sodium supports practical workflows spanning osteoclast assays, nano-enabled pulmonary delivery, and exploratory lung or tumor-cell studies. This guide connects FPPS inhibition with formulation QC, assay controls, and troubleshooting for more reproducible bone metabolism research.
-
Ciclesonide (B3477) for Reliable Cell Assays
2026-08-28
Learn how Ciclesonide (SKU B3477) can improve interpretation of airway-cell viability, proliferation, and inflammation assays by accounting for prodrug activation, solvent compatibility, and glucocorticoid receptor potency. The guide also distinguishes established Ciclesonide pharmacology from emerging ERAD-hijacking research.
-
H-89: cAMP-Dependent Protein Kinase Inhibitor
2026-08-28
H-89 is a cAMP-dependent protein kinase inhibitor used to test protein kinase A contributions to cAMP signaling, metabolism, proliferation, and apoptosis. Its reported 48 nM PKA IC50 supports biochemical pathway interrogation, but cellular conclusions require selectivity controls and orthogonal validation.
-
DDX21–NAT10 Signaling in Colorectal Cancer Metastasis
2026-08-27
The reference study identifies a DDX21–SIRT7–NAT10 regulatory axis that connects RNA-binding protein competition with ac4C-dependent stabilization of metastasis- and angiogenesis-associated transcripts in colorectal cancer. Its combination of clinical profiling, cellular perturbation, and in vivo validation provides a mechanistic framework for interpreting DDX21 as a potential therapeutic target, while also clarifying why RNA stability can be as important as transcriptional output in tumor progression.